Excellent adherence to hormonal therapy among patients with ductal carcinoma in situ plays a key role in reducing risk of future tumors, researchers found.
Sirius Medical, the leader in surgical marker navigation, is proud to be the platinum sponsor of the 42nd European Society of Surgical Oncology (ESSO) Congress in Florence, Italy.
MIT researchers have developed a wearable ultrasound device that can detect early-stage breast tumors between routine mammograms. Quality of the scans is similar to those captured by ultrasound probes in imaging centers.